Australian Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Entropy Neurodynamics

Market Cap: AU$51.5m

A clinical-stage pharmaceutical development company, focuses on developing formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs in Australia, Canada, Switzerland, and the United States.

Vitrafy Life Sciences

Market Cap: AU$91.6m

Engages in the research, development, and commercialization of cryopreservation solutions in Australia.

Firebrick Pharma

Market Cap: AU$13.0m

Engages in the development and commercialization of povidone-iodine (PVP-I) products under the Nasodine brand in Asia, North America, Europe, and internationally.

Vita Life Sciences

Market Cap: AU$135.5m

A healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China.

Clinuvel Pharmaceuticals

Market Cap: AU$640.1m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

OncoSil Medical

Market Cap: AU$19.8m

A medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma.

Avecho Biotechnology

Market Cap: AU$36.7m

A biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, the Americas, and India.

Prescient Therapeutics

Market Cap: AU$97.8m

A clinical stage oncology company, develops drugs for the treatment of haematological and solid cancers in Australia.

Immutep

Market Cap: AU$545.3m

A biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia.

LTR Pharma

Market Cap: AU$91.7m

A clinical-stage pharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia.

Proteomics International Laboratories

Market Cap: AU$78.6m

Operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and Southeast Asia.

Neuren Pharmaceuticals

Market Cap: AU$2.4b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

Nyrada

Market Cap: AU$203.0m

A pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases.

Arovella Therapeutics

Market Cap: AU$96.1m

A biotechnology company, engages in the development of therapies for the treatment of cancer in Australia and internationally.

Algorae Pharmaceuticals

Market Cap: AU$25.3m

A pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand.

Radiopharm Theranostics

Market Cap: AU$50.3m

A clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs.

Medical Developments International

Market Cap: AU$58.6m

Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.

Syntara

Market Cap: AU$52.2m

Operates as a clinical-stage drug development company that targets extracellular matrix dysfunction through amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis in Australia.

Argenica Therapeutics

Market Cap: AU$34.7m

A biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia.

Hexima

Market Cap: AU$2.2m

Does not have significant operations.

Invex Therapeutics

Market Cap: AU$9.0m

A biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia.

Aroa Biosurgery

Market Cap: AU$226.0m

Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.

Biotron

Market Cap: AU$4.2m

A biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia.

Dimerix

Market Cap: AU$363.2m

A biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia.

Clarity Pharmaceuticals

Market Cap: AU$1.1b

A clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States.

Cleo Diagnostics

Market Cap: AU$86.1m

A biotechnology company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia.

BCAL Diagnostics

Market Cap: AU$36.8m

A screening and diagnostic company, engages in developing a novel blood screening test to improve the diagnosis and monitoring of breast cancer.

Genetic Signatures

Market Cap: AU$52.2m

Operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas.

Patrys

Market Cap: AU$9.5m

Develops antibody technologies for the treatment of cancer and NETosis-driven inflammatory diseases.

Racura Oncology

Market Cap: AU$458.6m

A clinical stage biopharmaceutical company, focuses on addressing the unmet needs of cancer patients for damaging treatments in Australia.

Trajan Group Holdings

Market Cap: AU$96.9m

Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.

Neurizon Therapeutics

Market Cap: AU$61.5m

A clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases.

Island Pharmaceuticals

Market Cap: AU$125.1m

A drug repurposing company, focuses on the development of antiviral therapeutics for antiviral therapeutics in Australia and the United States of America.

Tissue Repair

Market Cap: AU$24.8m

A clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia.

Immuron

Market Cap: AU$11.1m

A biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada.

Amplia Therapeutics

Market Cap: AU$69.3m

A clinical-stage drug development company, engages in the development of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia.